# Translating Basic Science Discoveries into Clinical Advances: Highlights from the EACR-AACR-IACR 2024 Conference in Celebration of Irish Association for Cancer Research’s 60th Anniversary

## TL;DR

This conference report highlights recent cancer research advancements and collaborations from a major 2024 event celebrating the IACR's 60th anniversary.

## Contribution

The paper provides a summary of key research topics and breakthroughs presented at a high-profile international cancer research conference.

## Key findings

- Experts discussed advancements in immunotherapy, drug combinations, and cell-based therapies.
- Key sessions focused on liquid biopsies, epigenetics, and novel drug targets for cancer treatment.
- The conference fostered international collaboration and knowledge exchange in oncology research.

## Abstract

The EACR-AACR-IACR 2024 Conference, held in Dublin, Ireland, marked the 60th anniversary of the Irish Association for Cancer Research (IACR). Organized in partnership with leading European and American cancer research organizations, the event brought together top scientists and clinicians to discuss the latest breakthroughs in cancer research. Over three days, experts explored new treatments, drug therapies, immunotherapy, and early cancer detection methods. Keynote speakers shared insights on improving cancer care. This report summarizes the most important topics discussed, highlighting progress in cancer research and future directions for better treatments.

The EACR-AACR-IACR 2024 Basic and Translational Research Conference, held in Dublin, Ireland, from 27th–29th February, 2024, marked a significant milestone as part of the 60th anniversary celebrations of the Irish Association for Cancer Research (IACR). Organized in collaboration with the European Association for Cancer Research (EACR) and the American Association for Cancer Research (AACR), this prestigious event brought together leading experts in oncology research from around the world. The conference provided a platform for cutting-edge discussions on the latest advancements in immunotherapy, drug combinations, cell-based therapies, liquid biopsies, epigenetics, tumour microenvironment, and novel drug targets. With keynote lectures from esteemed researchers such as Kevan Shokat, Jerome Galon, Suzanne Topalian, and Scott Lowe, the conference facilitated knowledge exchange and fostered international collaboration in the pursuit of improved cancer treatments. The report highlights the key sessions, research breakthroughs, and discussions that shaped this landmark event.